Regulatory & Legal

Bosnia and Herzegovina's top operator is overhauling its core tech for the 5G era, partnering with Qvantel for a modern, cloud-native platform.

A key partnership, backed by the Saskatchewan government, is pioneering advanced DLE technology to unlock Canada's vast lithium brine resources for the EV market.

A new study uses PET-CT scans to track CIT-013, a first-in-class antibody targeting the root cause of inflammation in rheumatoid arthritis and HS.

Nawal Ouzren steps down as CEO for personal reasons just after a €60M financing. Chairman Amit Munshi takes over as the biotech faces key milestones.

Thomas Pritzker ends his 45-year tenure at Hyatt, citing 'terrible judgment' in his Epstein ties while positioning the move as 'good stewardship.'

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

Greece signs a landmark deal with Chevron and HELLENiQ for deep-sea hydrocarbon exploration, seeking energy independence amid high environmental stakes.

After a costly regulatory exit, crypto giant Nexo plans a 2026 U.S. return, partnering with Bakkt in a bid to redefine compliant digital finance.

A lawsuit claims a specialized pediatric daycare failed to protect a vulnerable child, leading to unexplained injuries and a state investigation.

A new partnership combines fitness and philanthropy, leveraging a national anti-bullying movement to support youth programs across Canada. Here's how you can join.

New drill results confirm a shallow, rich copper-gold zone at La Verde, boosting the economics of the Costa Fuego project with a potential starter pit.

With a key gas deal signed, construction begins on the world's largest ultra-low carbon methanol plant in Sinaloa, a $3.3B bet on sustainable fuels.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

Amid unprecedented supply chain chaos, Westrock Coffee met its 100% responsible sourcing goal. Here's how they did it and what it means for the industry.

With no approved nonsurgical options for plantar fibromatosis, Keenova's new study and late-stage trial offer a significant glimmer of hope for sufferers.

After a brutal 2024 and a massive strategy shift, all eyes are on Stellantis's 2025 earnings. Will the numbers justify its painful pivot away from EVs?

A new platform debuts, offering access to 30,000+ global assets from a single account, aiming to dismantle barriers for long-term retail investors.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

The USB-C market is set to quadruple, driven by global regulations and advanced tech. But what are the hidden costs and who is winning the race to dominate?

Indian startup DUSQ lands ₹24 crore to challenge global sleep-tech giants with a novel platform that promises to restore sleep, not just score it.